MiniMed Group, Inc. Common Stock (MMED) vs PTC Therapeutics, Inc. (PTCT)

A side-by-side comparison of MiniMed Group, Inc. Common Stock and PTC Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
MiniMed Group, Inc. Common Stock logo
MMED
MiniMed Group, Inc. Common Stock
$5.54B
$19.73HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
PTC Therapeutics, Inc. logo
PTCT
PTC Therapeutics, Inc.
$5.34B
$63.99HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — MMED vs PTCT

growth of $100 · dividends reinvested · last 1y
MMED +9.0% (+9.0%/yr)PTCT +1.3% (+1.3%/yr)MMED compounded faster over this window
6080100120140Start $100$109$101
MMED PTCT

MMED vs PTCT: by the numbers

  • •MMED is the larger company ($5.54B vs $5.34B market cap).
  • •Both run net losses; PTCT's is the smaller (-3.80% vs -10.21% net margin).

Metrics side by side

Valuation

MetricMMEDPTCT
Forward P/E29.3050.36
P/S ratio1.725.29
P/B ratio1.53N/A
EV / EBITDA30.8129.07

Profitability

MetricMMEDPTCT
Gross margin53.85%95.85%
Operating margin0.53%49.49%
Net margin-10.21%-3.80%
ROE-9.09%N/A
ROIC0.43%4.59%

Growth (annualized)

MetricMMEDPTCT
Revenue CAGR (5Y)N/A16.41%
Total return CAGR (5Y)N/A11.75%

Go deeper

Full MMED analysisFull PTCT analysisInteractive comparison tool

Dig into the metrics

MiniMed Group, Inc. Common Stock ROEPTC Therapeutics ROEMiniMed Group, Inc. Common Stock operating marginPTC Therapeutics operating marginMiniMed Group, Inc. Common Stock revenue growthPTC Therapeutics revenue growthMiniMed Group, Inc. Common Stock free cash flowPTC Therapeutics free cash flow

MiniMed Group, Inc. Common Stock & PTC Therapeutics appear in these rankings

Fastest Revenue Growth StocksHighest Operating Margin StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.